Johnson & Johnson Vision Care

Johnson & Johnson Vision (JJV) is the vision-care business of Johnson & Johnson and forms part of the company's Johnson & Johnson MedTech segment. It combines two principal activities: Johnson & Johnson Surgical Vision, which supplies technologies and products for cataract, refractive, corneal, and other ophthalmic procedures, and Johnson & Johnson Vision Care, whose best-known business is the ACUVUE contact-lens franchise. The organization was created in its present form after Johnson & Johnson acquired Abbott Medical Optics (AMO) in 2016 and subsequently renamed the business Johnson & Johnson Vision in February 2017. The business has roots in two different histories. Its contact-lens lineage began in 1959, when Frontier Contact Lenses was established in Buffalo, New York. Johnson & Johnson acquired Frontier in 1981, providing the foundation for its later contact-lens activities. The surgical lineage developed through a succession of ophthalmic-technology companies. Heyer-Schulte established an ophthalmic research division focused on aphakic lenses and extended-wear cosmetic contact lenses; after American Hospital Supply acquired Heyer-Schulte in 1974, the division became American Medical Optics (AMO). AMO concentrated on intraocular lenses and later expanded into phacoemulsification, viscoelastic materials, glaucoma implants, refractive lasers, and other surgical technologies. The ACUVUE brand became a major milestone in consumer vision care when Johnson & Johnson introduced what it described as the world's first disposable soft contact lenses in 1987. In surgical ophthalmology, the portfolio was broadened through acquisitions and internal development. Advanced Medical Optics acquired Pfizer's surgical ophthalmology business, Visx, WaveFront Sciences, and IntraLase during the 2000s. These transactions added intraocular lenses, excimer-laser systems, wavefront diagnostics, femtosecond-laser technology, and equipment supporting all-laser LASIK. Abbott acquired Advanced Medical Optics in 2009, renamed it Abbott Medical Optics, and later added Visiogen and OptiMedica. Today, JJV's product scope includes disposable and reusable contact lenses, contact-lens care and rewetting products, intraocular lenses for cataract surgery, phacoemulsification systems, ophthalmic viscoelastics, refractive-surgery lasers, wavefront diagnostic systems, microkeratomes, femtosecond lasers, glaucoma implants, and other products used by eye-care professionals. Its surgical portfolio has included brands such as TECNIS, Catalys, WHITESTAR, Healon, STAR, WaveScan, IntraLase, and iFS, while ACUVUE remains its most prominent consumer-facing offering. JJV employs approximately 4,200 people worldwide according to the referenced Wikipedia account. Surgical Vision is based in Santa Ana, California, while Vision Care is based in Jacksonville, Florida. The company markets products internationally and serves both professional customers, including ophthalmologists, hospitals, and surgical centers, and consumers who purchase contact lenses and associated eye-care products. Because it is a business within Johnson & Johnson rather than an independently listed company, JJV does not have a separate public ticker or independently reported stock-market status.

Johnson & Johnson's modern contact-lens business developed through Vistakon, an operation based in Jacksonville, Florida. The business was established in 1985 and focused on applying disposable-lens technology to routine vision correction. In 1987 it introduced ACUVUE in the United States. The product was marketed as a frequent-replacement lens, helping establish a category between conventional reusable lenses and truly daily disposable products. Its replacement schedule and emphasis on convenience, comfort, and hygiene contributed to the wider consumer adoption of soft contact lenses. During the 1990s and 2000s, the business extended ACUVUE into additional replacement schedules and prescriptions. Product development addressed astigmatism through toric designs and presbyopia through multifocal designs. The company also expanded into daily disposable lenses and incorporated material and design changes intended to improve oxygen transmission, moisture retention, handling, and visual performance. Some ACUVUE products used ultraviolet-light-blocking features, although such lenses were not presented as substitutes for sunglasses or other forms of eye protection. Johnson & Johnson used Vistakon and ACUVUE as important parts of its consumer vision-care presence while maintaining relationships with optometrists, ophthalmologists, distributors, and retail channels. Products were introduced market by market because contact lenses are regulated medical devices and require local approvals, professional fitting practices, and market-specific labeling. The business consequently combined consumer marketing with professional education and clinical support. A major strategic change came in 2016, when Johnson & Johnson agreed to acquire Abbott Medical Optics. That transaction added products for cataract surgery, refractive surgery, and other ophthalmic procedures to the company's existing contact-lens capabilities. In 2017 Johnson & Johnson organized the combined activities under Johnson & Johnson Vision. The resulting platform was broader than the historical Johnson & Johnson Vision Care or Vistakon contact-lens operation: it addressed both consumer vision correction and professional eye surgery. The contact-lens side continued to develop new ACUVUE generations, including daily disposable products, silicone-hydrogel designs, multifocal and toric lenses, and products intended to manage changing light conditions. ACUVUE OASYS with Transitions, announced in 2018, was notable for using photochromic technology in a contact lens. Later products such as ACUVUE OASYS MAX 1-Day reflected the company's emphasis on daily replacement and visual performance. Today, Johnson & Johnson Vision Care is most accurately described as the historical and operating contact-lens identity within Johnson & Johnson Vision, rather than a separately listed corporation. ACUVUE remains its principal consumer brand. The broader Johnson & Johnson Vision organization also includes professional ophthalmic products inherited or developed through the Abbott Medical Optics platform. Corporate naming has evolved, but the business continues to operate within Johnson & Johnson's MedTech activities and serves international vision-correction and eye-surgery markets.

• 2018

  ACUVUE OASYS with Transitions launched

  [6]ACUVUE OASYS with Transitions launchedjnj.com

  The company introduced a photochromic contact lens designed to adapt to changing light conditions.

• 2017

  Johnson & Johnson Vision formed

  [4]Johnson & Johnson Vision launches as a global vision-care organizationjnj.com

  Johnson & Johnson combined its existing vision-care activities with Abbott Medical Optics under the Johnson & Johnson Vision organization.

• 2016

  Abbott Medical Optics acquisition announced

  [3]Johnson & Johnson to acquire Abbott Medical Opticsjnj.com

  Johnson & Johnson announced an agreement to acquire Abbott Medical Optics, adding ophthalmic-surgery products and technologies.

• 1987

  ACUVUE introduced

  [2]ACUVUE official websiteacuvue.com

  ACUVUE was introduced in the United States as a frequent-replacement soft contact lens.

• 1985

  Vistakon established

  [5]Vistakon establishedjnjvisioncare.com

  Johnson & Johnson's contact-lens operation associated with Vistakon was established in Jacksonville, Florida.

A global eye-care and vision-correction business combining mass-market contact lenses with professional ophthalmic products and services. ACUVUE is positioned around convenience, comfort, replacement hygiene, and technology, while the broader Johnson & Johnson Vision platform targets eye-care professionals and surgical care.

• Contact-lens brand · 1987

  ACUVUE

  ACUVUE is Johnson & Johnson Vision's principal consumer contact-lens brand. Its portfolio has included daily disposable, two-week replacement, and other soft-lens formats, with prescriptions for myopia, hyperopia, astigmatism, and presbyopia. Product families differ by market and regulatory authorization.

• Frequent-replacement and specialty contact lenses

  ACUVUE OASYS

  ACUVUE OASYS is a family of soft contact lenses associated with silicone-hydrogel materials and designs intended to support comfort and oxygen transmission. Variants have addressed standard prescriptions, astigmatism, presbyopia, daily wear, and changing-light conditions.

• Daily disposable contact lenses

  1-DAY ACUVUE MOIST

  1-DAY ACUVUE MOIST is a daily disposable lens family designed for single-day use. Its positioning emphasizes convenience, reduced lens-maintenance requirements, and moisture-related comfort. Available prescriptions and exact product specifications vary by country.

• Photochromic contact lenses · 2018

  ACUVUE OASYS with Transitions

  ACUVUE OASYS with Transitions uses photochromic technology intended to adjust visible-light transmission as ambient lighting changes. It was developed for wearers seeking a contact-lens option that responds to bright and changing light, subject to prescription and market availability.

• Ophthalmic surgical products · 2017

  Johnson & Johnson Vision ophthalmic surgery portfolio

  Following the acquisition of Abbott Medical Optics, the broader Johnson & Johnson Vision organization included products and technologies used in cataract surgery, laser refractive surgery, and related ophthalmic procedures. These professional products are distinct from the consumer ACUVUE contact-lens portfolio.

• 2007

  AMO recalls Complete MoisturePlus contact-lens solution

  Advanced Medical Optics recalled Complete MoisturePlus after the product was associated with Acanthamoeba keratitis infections.

  Source

• 2007

  Complete MoisturePlus linked to Acanthamoeba keratitis cases

  In May 2007, health authorities and AMO linked Complete MoisturePlus contact-lens solution to cases of Acanthamoeba keratitis, a serious eye infection. AMO announced a recall, and a user lawsuit followed. The referenced material also reported allegations that several complaints had not been promptly reported to regulators.

  Source

• 2006

  Voluntary recall linked to manufacturing sterility concerns

  AMO voluntarily recalled certain products after an isolated bacterial-contamination problem affecting two production lines raised concerns that product sterility could have been compromised. The referenced account characterized the issue as a manufacturing-process problem rather than a formulation defect.

  Source

Read more

• 2017

  Create the Johnson & Johnson Vision platformStrategy

  Background

  The Abbott Medical Optics transaction created an opportunity to organize contact-lens and ophthalmic-surgery activities as one global vision-care business.

  Action taken

  Johnson & Johnson launched Johnson & Johnson Vision and positioned it as a combined platform serving patients and eye-care professionals.

  Aftermath

  The former Vision Care and Vistakon contact-lens activities became part of a broader organization spanning consumer vision correction and surgical eye care.

  Source

• 2016

  Acquire Abbott Medical OpticsM&A

  Background

  Johnson & Johnson sought to broaden its eye-care platform beyond contact lenses into ophthalmic surgery and related professional technologies.

  Action taken

  The company announced an agreement to acquire Abbott Medical Optics from Abbott Laboratories.

  Aftermath

  The acquisition was completed and its activities were subsequently combined with Johnson & Johnson's existing vision businesses under Johnson & Johnson Vision.

  Source

• 2021-07-16

  Johnson & Johnson Vision and China Eye Valley announce strategic partnership[8]强生视力健与中国眼谷宣布战略合作prnasia.com

  Reported: 2021-07-17

  Johnson & Johnson Vision and China Eye Valley announced a strategic cooperation agreement to collaborate on areas including industry-chain upgrading, research, academic exchange, R&D innovation, talent development, and public eye-health initiatives.

1. 1Johnson & Johnson Visionjnjvisionpro.com
2. 2ACUVUE official websiteacuvue.com
3. 3Johnson & Johnson to acquire Abbott Medical Opticsjnj.com
4. 4Johnson & Johnson Vision launches as a global vision-care organizationjnj.com
5. 5Vistakon establishedjnjvisioncare.com
6. 6ACUVUE OASYS with Transitions launchedjnj.com
7. 7AMO recalls Complete MoisturePlus contact-lens solutionen.wikipedia.org
8. 8强生视力健与中国眼谷宣布战略合作prnasia.com